Results
1 -
10 of
35
(Click
here to explore results)
Conference on Drug Design and Discovery Technologies, Development of New Neprilysin Inhibitor as a Modulator of Chronic Kidney and Heart Disease Using In Silico Drug Repurposing Approach R. Sankhe, A. Kumar, E. Rathi, A. Kishore
, 2020
, Pages 45-49New Horizons in Predictive Toxicology: Current Status and Application, Chapter 22 Impact of Drug Transporters in the Pharmacological and Adverse Reactions of Drugs Hiroyuki Kusuhara, Kazuya Maeda, Yuichi Sugiyama
, 2012
, Pages 563-598Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 3 Carboxylic Acids and their Bioisosteres Amit S. Kalgutkar, J. Scott Daniels
, 2010
, Pages 99-167Drug Transporters: Volume 2: Recent Advances and Emerging Technologies, Chapter 4 Interplay Between Enzymes and Transporters: Impact on the Prediction of Pharmacokinetics and Drug–Drug Interactions Karelle Ménochet, Hugues Chanteux
, 2016
, Volume 2
, Pages 73-113Synthetic Methods in Drug Discovery: Volume 1, Chapter 9 Palladium-catalyzed Decarboxylative Couplings Christophe Linder, Nuria Rodríguez
, 2016
, Volume 1
, Pages 384-410Designing Multi-Target Drugs, Chapter 19 Designing Drugs with Dual Activity: Novel Dual Angiotensin II and Endothelin Receptor Antagonists Natesan Murugesan
, 2012
, Pages 316-334Pharmaceutical Process Development: Current Chemical and Engineering Challenges, Chapter 1 Introduction A. John Blacker, Mike T. Williams
, 2011
, Pages 1-14Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 1 Privileged Scaffolds in Medicinal Chemistry: An Introduction Eliezer J. Barreiro
, 2016
, Pages 1-15Anti-fibrotic Drug Discovery, CHAPTER 1 TGFβ Signaling Anne-Ulrike Trendelenburg
, 2020
, Pages 1-36Drug Transporters: Volume 2: Recent Advances and Emerging Technologies, Chapter 3 Targeted Proteomics to Support Transporter IVIVE and PBPK Aki T. Heikkinen, Neil Parrott, Tom Dunkley, Paul Cutler
, 2016
, Volume 2
, Pages 44-72